Royalty Pharma plc (RPRX) NASDAQ

39.55

-0.17(-0.43%)

Updated at January 16 04:00PM

Currency In USD

Valuation

Market Cap11.38B
Enterprise Value18.06B
P/E Ratio22.33
PEG Ratio-0.93
Price/Sales Ratio7.31
Price/Book Ratio2.66
Enterprise/Revenue10.72
Enterprise/EBITDA15.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.33
Operating Margin0.65

Management Effectiveness

Return On Assets0.04
Return On Equity0.12

Income Statement

Revenue2.26B
Revenue/Share5.44
Gross Profit2.26B
EBITDA1.56B
Net Income858.98M
Diluted EPS1.91

Balance Sheet

Total Cash955.04M
Total Cash/Share2.21
Total Debt8.97B
Total Debt/Equity1.4
Current Ratio3.48
Book Value Per Share22.28

Price History

52-Week Change30.53
52-Week High41.7
52-Week Low29.66
Moving Average 50 Days39.33
Moving Average 200 Days36.11

Statistics

Average Volume3.95M
Shares Outstanding434.11M
% Held by Institutions75.8

Dividend And Splits

Trailing Annual Dividend Rate0.88
Trailing Annual Dividend Yield2.23
Payout Ratio0.49
Last Split FactorN/A
Last Split DateN/A